Qube Research & Technologies (QRT)’s Organogenesis Holdings ORGO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-287,768	Closed	-$1.24M	–	3853
2025 Q1	$1.24M	Buy	287,768 +184,692	+179%	+$746K	﹤0.01%	2175
2024 Q4	$330K	Buy	103,076 +65,734	+176%	+$221K	﹤0.01%	2675
2024 Q3	$107K	Buy	37,342 +35,172	+1,621%	+$98.6K	﹤0.01%	2733
2024 Q2	$6.08K	Sell	2,170 -79,033	-97%	-$212K	﹤0.01%	3012
2024 Q1	$231K	Buy	+81,203	New	+$276K	﹤0.01%	2956
2023 Q4	–	Sell	-32,630	Closed	-$104K	–	4630
2023 Q3	$104K	Sell	32,630 -97,025	-75%	-$308K	﹤0.01%	2649
2023 Q2	$430K	Sell	129,655 -168,391	-56%	-$498K	﹤0.01%	1550
2023 Q1	$635K	Buy	298,046 +236,884	+387%	+$585K	﹤0.01%	1469
2022 Q4	$165K	Sell	61,162 -254,056	-81%	-$741K	﹤0.01%	1874
2022 Q3	$1.02M	Buy	315,218 +210,450	+201%	+$951K	0.01%	1189
2022 Q2	$511K	Sell	104,768 -4,592	-4%	-$28.3K	﹤0.01%	1400
2022 Q1	$833K	Sell	109,360 -4,799	-4%	-$37.1K	0.01%	1261
2021 Q4	$1.05M	Buy	114,159 +88,023	+337%	+$935K	0.01%	1155
2021 Q3	$372K	Buy	+26,136	New	+$406K	﹤0.01%	1380

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ORGO Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 287,768 shares — an estimated $1.24M sold.

Qube Research & Technologies (QRT) first reported a position in ORGO in Q3 2021 and held it in 14 quarters. The position peaked at $1.24M in Q1 2025. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

Qube Research & Technologies (QRT) reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 287,768 Organogenesis Holdings shares in Q2 2025, an estimated $1.24M.
Qube Research & Technologies (QRT) first reported a position in Organogenesis Holdings in Q3 2021 and held it in 14 quarters.
Qube Research & Technologies (QRT)'s Organogenesis Holdings position peaked at $1.24M in Q1 2025.
115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.